Cyclomedica Danmark ApS: Financial statements 2022
CVR: 16582891
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Cyclomedica Danmark ApS (CVR 16582891) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 622,242 and a net result of DKK -394,454 compared with DKK -379,161 the year before. That is a decrease of 7.2% compared with the year before. Equity in the 2022 report amounted to DKK 1,027,677. The solvency ratio was 55.9%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 622,242
- Profit/Loss
- DKK -394,454
- Equity
- DKK 1,027,677
- Total Assets
- DKK 1,839,660
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 622K | -394K | 1M | 3 |
| 2021 | - | 671K | -379K | 1.4M | 3 |
| 2020 | - | 1.3M | 115K | 1.9M | 3 |
| 2019 | - | 1.7M | 425K | 2.2M | 3 |
| 2018 | - | 1.7M | 373K | 2.1M | 3 |
Official annual report
Keep an eye on Cyclomedica Danmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Cyclomedica Danmark ApS has published its annual report for 2021. Gross profit came to DKK 670,823, and the net result was DKK -379,161.
About Cyclomedica Danmark ApS
Cyclomedica Danmark ApS is a Danish company of the type Anpartsselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named DUPHARMA ApS and DUPHARMA A/S. The management consists of Jan Fritz Rode Jakobsen. The board consists of James Steven Mc Brayer and Mathew Farag. The company is owned by Cyclomedia Europe Limited. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 559,660 and a net result of DKK 135,961 compared with DKK -5,806 the year before. Equity in the 2025 report amounted to DKK 478,864.